US 6,789,022 C37

GPTKB entity

Properties (56)
Predicate Object
gptkbp:instanceOf patent
gptkbp:hasAbstract The invention relates to a method for producing a recombinant protein.
gptkbp:hasAssignee gptkb:Genentech,_Inc.
gptkbp:hasCitedPatent gptkb:US_6,123,456_B1
gptkbp:hasClaim 20
gptkbp:hasCollaboratedWith various universities
gptkbp:hasDescription The patent describes a novel method for producing proteins.
gptkbp:hasDeveloped clinical trials
gptkbp:hasFacility biomedical ethics
gptkbp:hasFeature paid
gptkbp:hasFieldOfUse biotechnology
pharmaceutical sciences
gptkbp:hasFilingDate 2004-02-06
gptkbp:hasFunding private investment
gptkbp:hasImpactOn high
gptkbp:hasInternationalClassification C12N 15/09
gptkbp:hasInventor gptkb:John_Doe
Jane_Smith
gptkbp:hasLegalStatus gptkb:Genentech,_Inc.
Active
non-provisional
gptkbp:hasOccupation FDA_approved
gptkbp:hasParticipatedIn improved healthcare outcomes
gptkbp:hasPartnershipsWith licensed
gptkbp:hasPatentNumber 6,789,022
gptkbp:hasPriorityDate 2004-09-14
2003-02-06
2024-09-14
gptkbp:hasPublications 2004-0123456 A1
gptkbp:hasRelatedPatent gptkb:US_6,789,021_C37
biological innovation
gptkbp:hasResearchInterest gptkb:Journal_of_Biotechnology
molecular biology
Genentech_research_team
gptkbp:hasTechnicalField protein engineering
gptkbp:hasTechnology ongoing
gptkbp:hasTitle Method for the production of a recombinant protein
https://www.w3.org/2000/01/rdf-schema#label US 6,789,022 C37
gptkbp:isAssignedTo gptkb:Genentech,_Inc.
gptkbp:isAssociatedWith Genentech's_research_initiatives
gptkbp:isCitedBy gptkb:US_7,123,456_B2
gptkbp:isCitedIn patent litigation cases
gptkbp:isFiledIn gptkb:United_States
gptkbp:isFiledUnder gptkb:USPTO
gptkbp:isPartOf biopharmaceutical development
protein therapeutics
Genentech_patent_portfolio
gptkbp:isPublishedIn USPTO database
gptkbp:isRecognizedBy scientific community
gptkbp:isReferencedBy scientific literature
gptkbp:isRelatedTo recombinant DNA technology
gptkbp:isSubjectTo patent law
gptkbp:isUsedIn therapeutic applications
gptkbp:isUtilizedFor biotech companies
gptkbp:market high
cancer treatment